Last reviewed · How we verify

NCT07039136

Virtual Reality Mirrors Therapy Usability

Recruiting now NA Last updated 5 February 2026
What this trial tests

NA trial testing Virtual Reality Mirror Therapy in Healthy in 172 participants. Currently enrolling.

Timeline
28 June 2025
Primary endpoint
30 October 2026
30 November 2026

Quick facts

Lead sponsorAbant Izzet Baysal University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment172
Start date28 June 2025
Primary completion30 October 2026
Estimated completion30 November 2026
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Abant Izzet Baysal University

Who can join

Adults 18 to 60, any sex, with Healthy or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mirror therapy has been shown to support motor recovery by stimulating neural mechanisms through visual feedback. Recent technological advancements, particularly in virtual reality (VR), have enabled the development of more immersive and interactive rehabilitation tools. This study focuses on evaluating the usability of a novel, Leap Motion-based Virtual Reality Mirror Therapy (VRMT) system designed to enhance upper limb rehabilitation in stroke patients by combining traditional mirror therapy principles with engaging, gamified digital environments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual Reality Mirror Therapy

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Abant Izzet Baysal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07039136.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing